162. Pemphigoid Clinical trials / Disease details
Clinical trials : 83 / Drugs : 128 - (DrugBank : 51) / Drug target genes : 33 - Drug target pathways : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR1800017560 | 2018-08-31 | 2018-08-04 | Association of serum D-dimer and PDF with the BP severity | Association of serum D-dimer and PDF with the BP severity | Bullous pemphigoid | Gold Standard:Clinical outcome;Index test:D-dimer, FDP, anti-BP180 IgG; | the Second Affiliated Hospital, Xi'an Jiaotong University | NULL | Pending | 18 | 90 | Both | Target condition:160;Difficult condition:0 | China |